Clinical trial
A Randomized Controlled Trial Comparing the Efficacy of Intranasal Midazolam and Conventional Treatment With Intravenous Diazepam for Control of Seizures in Children
NCT04885075 is registered in ClinicalTrials.gov with Shaheed Zulfiqar Ali Bhutto Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial Comparing the Efficacy of Intranasal Midazolam and Conventional Treatment With Intravenous Diazepam for Control of Seizures in Children
- Lead sponsor
- Shaheed Zulfiqar Ali Bhutto Medical University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- May 30, 2021
- Completion date
- November 30, 2021
- Enrollment
- 60 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.